科伦博泰生物-B终止认购本金额9.8亿元的中国银行结构性存款

Core Viewpoint - The company has announced the termination of its investment in a structured deposit agreement with Bank of China, amounting to RMB 980 million, which will not incur any costs or penalties due to the timing of the termination within the investment cooling-off period [1] Group 1 - The company subscribed to a structured deposit agreement with Bank of China for a principal amount of RMB 980 million [1] - The termination of the subscription was executed on January 7, 2026, after further consideration and adjustment of the company's financial strategy [1] - The termination does not require the company to pay any amount or incur any additional fees or penalties [1]